|
1
|
Ronca R, Van Ginderachter JA and Turtoi A:
Paracrine interactions of cancer-associated fibroblasts,
macrophages and endothelial cells: Tumor allies and foes. Curr Opin
Oncol. 30:45–53. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weis SM and Cheresh DA: Tumor
angiogenesis: Molecular pathways and therapeutic targets. Nat Med.
17:1359–1370. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Billy F, Ribba B, Saut O, Morre-Trouilhet
H, Colin T, Bresch D, Boissel JP, Grenier E and Flandrois JP: A
pharmacologically based multiscale mathematical model of
angiogenesis and its use in investigating the efficacy of a new
cancer treatment strategy. J Theor Biol. 260:545–562. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bai Y, Bai L, Zhou J, Chen H and Zhang L:
Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric
system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
Cell Immunol. 323:19–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hosseini F and Naghavi N: Modelling
tumor-induced angiogenesis: combination of stochastic sprout
spacing and sprout progression. J Biomed Phys Eng. 7:233–256.
2017.PubMed/NCBI
|
|
7
|
Laschke MW, Harder Y, Amon M, Martin I,
Farhadi J, Ring A, Torio-Padron N, Schramm R, Rücker M, Junker D,
et al: Angiogenesis in tissue engineering: Breathing life into
constructed tissue substitutes. Tissue Eng. 12:2093–2104. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Feng T, Yu H, Xia Q, Ma Y, Yin H, Shen Y
and Liu X: Cross-talk mechanism between endothelial cells and
hepatocellular carcinoma cells via growth factors and integrin
pathway promotes tumor angiogenesis and cell migration. Oncotarget.
8:69577–69593. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Addison-Smith B, McElwain DL and Maini PK:
A simple mechanistic model of sprout spacing in tumour-associated
angiogenesis. J Theor Biol. 250:1–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chaplain MA, McDougall SR and Anderson AR:
Mathematical modeling of tumor-induced angiogenesis. Annu Rev
Biomed Eng. 8:233–257. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lamalice L, Le Boeuf F and Huot J:
Endothelial cell migration during angiogenesis. Circ Res.
100:782–794. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao D, Nolan DJ, Mellick AS, Bambino K,
McDonnell K and Mittal V: Endothelial progenitor cells control the
angiogenic switch in mouse lung metastasis. Science. 319:195–198.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chiarugi V, Ruggiero M and Magnelli L:
Molecular polarity in endothelial cells and tumor-induced
angiogenesis. Oncol Res. 12:1–4. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tei K, Kawakami-Kimura N, Taguchi O,
Kumamoto K, Higashiyama S, Taniguchi N, Toda K, Kawata R, Hisa Y
and Kannagi R: Roles of cell adhesion molecules in tumor
angiogenesis induced by cotransplantation of cancer and endothelial
cells to nude rats. Cancer Res. 62:6289–6296. 2002.PubMed/NCBI
|
|
17
|
Watnick RS: The role of the tumor
microenvironment in regulating angiogenesis. Cold Spring Harb
Perspect Med. 2:a0066762012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Samples J, Willis M and Klauber-DeMore N:
Targeting angiogenesis and the tumor microenvironment. Surg Oncol
Clin N Am. 22:629–639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chouaib S, Kieda C, Benlalam H, Noman MZ,
Mami-Chouaib F and Rüegg C: Endothelial cells as key determinants
of the tumor microenvironment: Interaction with tumor cells,
extracellular matrix and immune killer cells. Crit Rev Immunol.
30:529–545. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stroka KM, Vaitkus JA and Aranda-Espinoza
H: Endothelial cells undergo morphological, biomechanical, and
dynamic changes in response to tumor necrosis factor-α. Eur Biophys
J. 41:939–947. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo J, Liu C, Zhou X, Xu X, Deng L, Li X
and Guan F: Conditioned medium from malignant breast cancer cells
induces an EMT-Like Phenotype and an Altered N-Glycan profile in
Normal Epithelial MCF10A cells. Int J Mol Sci. 18(pii): E15282017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khodarev NN, Yu J, Labay E, Darga T, Brown
CK, Mauceri HJ, Yassari R, Gupta N and Weichselbaum RR:
Tumour-endothelium interactions in co-culture: Coordinated changes
of gene expression profiles and phenotypic properties of
endothelial cells. J Cell Sci. 116:1013–1022. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bjerregaard B, Holck S, Christensen IJ and
Larsson LI: Syncytin is involved in breast cancer-endothelial cell
fusions. Cell Mol Life Sci. 63:1906–1911. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dittmar T, Nagler C, Niggemann B and
Zanker KS: The dark side of stem cells: Triggering cancer
progression by cell fusion. Curr Mol Med. 13:735–750. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuhbier JW, Bucan V, Reimers K, Strauss S,
Lazaridis A, Jahn S, Radtke C and Vogt PM: Observed changes in the
morphology and phenotype of breast cancer cells in direct
co-culture with adipose-derived stem cells. Plast Reconstr Surg.
134:414–423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang LN, Kong CF, Zhao D, Cong XL, Wang
SS, Ma L and Huang YH: Fusion with mesenchymal stem cells
differentially affects tumorigenic and metastatic abilities of lung
cancer cells. J Cell Physiol. 234:3570–3582. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mortensen K, Lichtenberg J, Thomsen PD and
Larsson LI: Spontaneous fusion between cancer cells and endothelial
cells. Cell Mol Life Sci. 61:2125–2131. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
An R, Schmid R, Klausing A, Robering JW,
Weber M, Bäuerle T, Detsch R, Boccaccini AR, Horch RE, Boos AM and
Weigand A: Proangiogenic effects of tumor cells on endothelial
progenitor cells vary with tumor type in an in vitro and in vivo
rat model. Faseb J. 32:5587–5601. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ding Q, Xia Y, Ding S, Lu P, Sun L, Fan Y,
Li X, Wang Y, Tian DA and Liu M: Potential role of CXCL9 induced by
endothelial cells/CD133+ liver cancer cells co-culture
system in tumor transendothelial migration. Genes Cancer.
7:254–259. 2016.PubMed/NCBI
|
|
30
|
Lin SY, Yang J, Everett AD, Clevenger CV,
Koneru M, Mishra PJ, Kamen B, Banerjee D and Glod J: The isolation
of novel mesenchymal stromal cell chemotactic factors from the
conditioned medium of tumor cells. Exp Cell Res. 314:3107–3117.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Novosel EC, Kleinhans C and Kluger PJ:
Vascularization is the key challenge in tissue engineering. Adv
Drug Deliv Rev. 63:300–311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cartland SP, Genner SW, Zahoor A and
Kavurma MM: Comparative evaluation of TRAIL, FGF-2 and
VEGF-A-induced angiogenesis in vitro and in vivo. Int J Mol
Sci. 17(pii): E20252016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wei B, Han XY, Qi CL, Zhang S, Zheng ZH,
Huang Y, Chen TF and Wei HB: Coaction of spheroid-derived stem-like
cells and endothelial progenitor cells promotes development of
colon cancer. PLoS One. 7:e390692012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang Y, Jin G, Liu H, Liu K, Zhao J, Chen
X, Wang D, Bai R, Li X and Jang Y: Metformin inhibits esophageal
squamous cell carcinoma-induced angiogenesis by suppressing
JAK/STAT3 signaling pathway. Oncotarget. 8:74673–74687.
2017.PubMed/NCBI
|
|
36
|
Katkoori VR, Basson MD, Bond VC, Manne U
and Bumpers HL: Nef-M1, a peptide antagonist of CXCR4, inhibits
tumor angiogenesis and epithelialtomesenchymal transition in colon
and breast cancers. Oncotarget. 6:27763–27777. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gasparini G and Harris AL: Clinical
importance of the determination of tumor angiogenesis in breast
carcinoma: much more than a new prognostic tool. J Clin Oncol.
13:765–782. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xiong YQ, Sun HC, Zhang W, Zhu XD, Zhuang
PY, Zhang JB, Wang L, Wu WZ, Qin LX and Tang ZY: Human
hepatocellular carcinoma tumor-derived endothelial cells manifest
increased angiogenesis capability and drug resistance compared with
normal endothelial cells. Clin Cancer Res. 15:4838–4846. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Duncan GS, Andrew DP, Takimoto H, Kaufman
SA, Yoshida H, Spellberg J, de la Pompa JL, Elia A, Wakeham A,
Karan-Tamir B, et al: Genetic evidence for functional redundancy of
platelet/endothelial cell adhesion molecule-1 (PECAM-1):
CD31-deficient mice reveal PECAM-1-dependent and
PECAM-1-independent functions. J Immunol. 162:3022–3030.
1999.PubMed/NCBI
|
|
40
|
Yu Y, Huang X, Di Y, Qu L and Fan N:
Effect of CXCL12/CXCR4 signaling on neuropathic pain after chronic
compression of dorsal root ganglion. Sci Rep. 7:57072017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Okada H, Tsuzuki T, Shindoh H, Nishigaki
A, Yasuda K and Kanzaki H: Regulation of decidualization and
angiogenesis in the human endometrium: Mini review. J Obstet
Gynaecol Res. 40:1180–1187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang P, Chen N, Jia JH, Gao XJ, Li SH, Cai
J and Wang Z: Tie-1: A potential target for anti-angiogenesis
therapy. J Huazhong Univ Sci Technolog Med Sci. 35:615–622. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zanetta L, Marcus SG, Vasile J, Dobryansky
M, Cohen H, Eng K, Shamamian P and Mignatti P: Expression of Von
Willebrand factor, an endothelial cell marker, is up-regulated by
angiogenesis factors: A potential method for objective assessment
of tumor angiogenesis. Int J Cancer. 85:281–288. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liang T, Zhu L, Gao W, Gong M, Ren J, Yao
H, Wang K and Shi D: Coculture of endothelial progenitor cells and
mesenchymal stem cells enhanced their proliferation and
angiogenesis through PDGF and Notch signaling. FEBS Open Bio.
7:1722–1736. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
West CC, Brown NJ, Mangham DC, Grimer RJ
and Reed MW: Microvessel density does not predict outcome in high
grade soft tissue sarcoma. Eur J Surg Oncol. 31:1198–1205. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis-correlation in invasive breast
carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tomlinson J, Barsky SH, Nelson S, Singer
S, Pezeshki B, Lee MC, Eilber F and Nguyen M: Different patterns of
angiogenesis in sarcomas and carcinomas. Clin Cancer Res.
5:3516–3522. 1999.PubMed/NCBI
|
|
48
|
Rocchi L, Caraffi S, Perris R and Mangieri
D: The angiogenic asset of soft tissue sarcomas: A new tool to
discover new therapeutic targets. Biosci Rep. 34:e001472014.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kami Reddy KR, Dasari C, Vandavasi S,
Natani S, Supriya B, Jadav SS, Sai Ram N, Kumar JM and Ummanni R:
Novel cellularly active inhibitor regresses DDAH1 induced prostate
tumor growth by restraining tumor angiogenesis through targeting
DDAH1/ADMA/NOS pathway. ACS Comb Sci. 2019.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lacal PM and Graziani G: Therapeutic
implication of vascular endothelial growth factor receptor-1
(VEGFR-1) targeting in cancer cells and tumor microenvironment by
competitive and non-competitive inhibitors. Pharmacol Res.
136:97–107. 2018. View Article : Google Scholar : PubMed/NCBI
|
